Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    

| More

Mishra Dhatu Nigam - Steady tidings - ICICI Securities

Posted On: 2020-09-13 22:04:09

Mishra Dhatu Nigam (Midhani) has reported a decent topline performance in Q1FY21 at Rs1.14bn (down 14% YoY). The reduction in topline reflects 45 days of shutdown in Q1. There has been a meaningful compression in gross margins from the quarterly runrate of FY20 - perhaps due to order mix. Q1FY21 would have been defence heavy to result in gross margins declining from 91% to 64% YoY. Given the breakup in FY20-end orderbook, with ~80% of orderbook comprising of space orders - FY21 execution for Midhani will be space heavy. We have seen a new timeline for Chandrayan III - with lander and rover and no orbiter. Budget allocation across GoI ministries should expectantly come down in H2FY21 - defence, space irrespective. However, the relatively smaller size of the space budget may still allow it to see lower contraction. We maintain BUY.

- Orderbook and order inflow. Current orderbook is Rs17.3bn against Rs16.8bn QoQ. Q1FY21 saw Rs1.62bn of order booking. Midhani has previously guided for FY21 order inflow at Rs7.5bn, 70% of which would be from defence. A large part of the order inflow may accrue from Akash (allotted to BDL), the future expected order of Tejas (Titanium alloys - another high value order which can help maintain margins similar to space order) etc.

- On Q1FY21 performance from FY20 annual report. There was a disruption in production activities for about 45 days in Q1FY21. Subsequently, normal production activities resumed with effect from May 20, 2020. Despatch of finished materials also started in the month of May 2020. With improvement in supply chain efficiency post phase-wise easing of the lockdown, management hopes to neutralise the impact of Covid-19 on business for Q1FY21 to some extent.

- Q1FY21 has seen more encouraging deliveries/ RM price movement for Midhani. This includes bulletproof jackets (Rohtak factory is yet to commission), titanium metal for chambers of Gaganayan mission for Indian cosmonauts. The MDN 250 slabs were also supplied to SAIL to roll into plates for Gaganayan mission. Also, there's expectantly a significant surplus expected in nickel due to aggressive nickel pig iron expansion in Indonesia. This can also help surprise margins if procurement can be planned out effectively.

- Maintain BUY. Low current utilisation and higher value blend through supplies to ISRO can help increase topline meaningfully over the next 2-3 years. We expect RoCE to cross 20% as topline accretion takes shape. Capex remains limited with ISRO's share increasing in Midhani's execution, improvement in working capital and moderate capex will also help generate FCF. Budget allocation to space and defence by the GoI in the current environment remains the only point of concern for continued order visibility for Midhani.

Shares of Mishra Dhatu Nigam Ltd was last trading in BSE at Rs.201.05 as compared to the previous close of Rs. 204.3. The total number of shares traded during the day was 26533 in over 737 trades.

The stock hit an intraday high of Rs. 205.05 and intraday low of 198. The net turnover during the day was Rs. 5380410.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Mazagon Dock IPO fully subscribed on Day 1 - Angel Broking

Pharma - Sector Thematic - Cardiac: the heartbeat of domestic market - HDFC Securities Institutional Research Desk

Walmart-Tata Retail Deal - Mr. Himanshu Nayyar, YES SECURITIES

HDFC Securities Institutional Research Desk: Chemical Conference Report

Lupin - Launch of Fosaprepitant - Angel Broking

Infosys - Key beneficiary of increased IT spending - Angel Broking

Gateway Distriparks - Holding structure simplified; prepared for next phase of growth - ICICI Securities

Visaka Industries - Demand and pricing tailwinds sustain; maintain a compelling BUY - ICICI Securities

GSK Pharmaceuticals - Analyst call highlights - Sep 28, 2020 - ICICI Securities

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Healthcare - Diagnostics: Multiple tailwinds likely to emerge - ICICI Securities

Mazagon Dock Shipbuilders Ltd - IPO Review - ICICI Securities

Persistent Systems - 28th September 2020 - Angel Broking

Canara Bank - 28th September 2020 - Angel Broking

Subscribe to UTI Asset Management Company Limited - IPO Note - Angel Broking

Multiplex Sector - Mr. Jyoti Roy - DVP - Equity Strategist, Angel Broking Ltd

Sale of Sequent stake to Strides Pharma - Angel Broking

Subscribe to Mazagon Dock Shipbuilders Ltd - IPO Note - Angel Broking

JSW Energy - First big renewable step - ICICI Securities

V-MART Retail - Best play in value fashion segment; initiating with BUY - ICICI Securities

Gas sector - New winners and losers likely on policy changes in gas sector - ICICI Securities

Mazagon Dock Shipbuilders Limited - IPO Note - Geojit

UTI Asset Management Company Limited - IPO Note - Geojit

Preview on RBI Monetary Policy - Oct 2020 - Shanti Ekambaram

Rollover Report for September 2020 - October 2020: Angel Broking

Covid Recovery Pulse - Sep 25, 2020 - ICICI Securities

Quick Comment - Suven Pharmaceuticals - ICICI Securities

Derivatives Strategy - Sep 25, 2020 - Positional Option - ICICI Securities

Gladiator Stocks - Ramco Cement - ICICI Securities

IPO Review - UTI Asset Management Company - ICICI Securities

Stock of the Day - Zensar Technologies - Sep 25, 2020 - Angel Broking

Accenture Q4FY2020 Result - Angel Broking

Granules India receives ANDA approval - Angel Broking

Zydus Cadila receives US FDA approval - Angel Broking

Cipla - ANDA approval - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Mindspace REIT - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

UTI AMC - IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

Balkrishna Industries - Growth momentum continues - ICICI Securities

Rollover Analysis (September 25): Nifty starts October series with low OI amid high volatility

Derivatives View (September 25): Sell Bank Nifty in range of 20650-20750 - ICICI Securities

Rollover Analysis - Sept 20: Selling climax on expiry as markets crumble - YES Securities

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019